Department of Psychiatry, Columbia University/ New York State Psychiatric Institute, 1051 Riverside Drive, New York, NY 10032, USA.
J Clin Psychiatry. 2010 Jul;71(7):831-8. doi: 10.4088/JCP.10m05969yel. Epub 2010 Apr 20.
This study seeks to identify patient, facility, county, and state policy factors associated with timely schizophrenia-related outpatient treatment following hospital discharge.
A retrospective longitudinal cohort analysis was performed of 2003 national Medicaid claims data supplemented with the American Hospital Association facility survey, the Area Resource File, and a Substance Abuse and Mental Health Services Administration Medicaid policy report. The analysis focuses on treatment episodes of adults, aged 20 to 63 years, who received inpatient care for ICD-9-CM-diagnosed schizophrenia (59,567 total treatment episodes). Rate and adjusted odds ratio (AOR) of schizophrenia-related outpatient visits within 7 days and 30 days following hospital discharge are assessed.
Of the 59,567 hospital discharges, 41.7% received schizophrenia-related outpatient visits in 7 days and 59.3% in 30 days following hospital discharge. The adjusted odds of 30-day follow-up outpatient visits were significantly related to preadmission outpatient mental health visits (AOR = 3.72; 99% CI, 3.44-4.03), depot (AOR = 2.83; 99% CI, 2.53-3.18) or oral (AOR = 1.73; 99% CI, 1.62-1.84) antipsychotics as compared with no antipsychotics, and absence of a substance use disorder diagnosis (AOR = 1.35; 99% CI, 1.25-1.45). General hospital as compared with a psychiatric hospital treatment (AOR = 1.32; 99% CI, 1.14-1.54) and patient residence in a county with a larger number of psychiatrists per capita (AOR = 1.27; 99% CI, 1.08-1.50) were related to receiving follow-up outpatient visits. By contrast, residence in a county with a high poverty rate (AOR = 0.60; 99% CI, 0.54-0.67) and treatment in a state with prior authorization requirements for < 12 annual outpatient visits (AOR = 0.69; 99% CI, 0.63-0.75) reduced the odds of follow-up care.
Patient characteristics, clinical management, geographical resource availability, and the mental health policy environment all appear to shape access to care following hospital discharge in the community treatment of adult schizophrenia.
本研究旨在确定与精神分裂症患者出院后及时进行相关门诊治疗相关的患者、医疗机构、县和州政策因素。
对 2003 年全国医疗补助数据进行了回顾性纵向队列分析,并补充了美国医院协会设施调查、区域资源文件和药物滥用和心理健康服务管理医疗补助政策报告。该分析主要关注接受 ICD-9-CM 诊断为精神分裂症(2003 年总治疗次数为 59567 次)住院治疗的 20-63 岁成年人的治疗发作。评估了出院后 7 天和 30 天内进行精神分裂症相关门诊治疗的比率和调整后的优势比(AOR)。
在 59567 次出院中,41.7%的患者在出院后 7 天内和 59.3%的患者在出院后 30 天内进行了精神分裂症相关的门诊治疗。30 天门诊随访的调整后优势与入院前门诊心理健康就诊(AOR=3.72;99%CI,3.44-4.03)、长效(AOR=2.83;99%CI,2.53-3.18)或口服(AOR=1.73;99%CI,1.62-1.84)抗精神病药物而非无抗精神病药物以及无物质使用障碍诊断(AOR=1.35;99%CI,1.25-1.45)显著相关。与精神病医院治疗相比,综合医院治疗(AOR=1.32;99%CI,1.14-1.54)和患者居住在每千人拥有更多精神科医生的县(AOR=1.27;99%CI,1.08-1.50)与接受随访门诊治疗相关。相比之下,居住在贫困率较高的县(AOR=0.60;99%CI,0.54-0.67)和在需要<12 次年度门诊就诊才能获得授权的州接受治疗(AOR=0.69;99%CI,0.63-0.75)降低了获得随访护理的几率。
患者特征、临床管理、地理资源可用性以及心理健康政策环境似乎都在塑造成年精神分裂症社区治疗出院后的护理机会。